Inhibiting the SARS-CoV-2-PLpro enzyme is a novel avenue to explore in rational design of COVID-19 drugs, according to new research.
Click here for original story, Viral ‘molecular scissor’ is next COVID-19 drug target
Source: ScienceDaily